SCHEDULE 13G: Dodge & Cox Discloses 8.5% Passive Stake in Humana Inc.
Beneficial Ownership Report
Investment adviser Dodge & Cox has reported a passive beneficial ownership of 8.5% in Humana Inc.'s common stock as of December 31, 2024.
Summary
- Dodge & Cox, an investment adviser based in San Francisco, CA, has filed a Schedule 13G regarding its beneficial ownership in Humana Inc.
- As of December 31, 2024, Dodge & Cox beneficially owned an aggregate of 10,198,040 shares of Humana Inc. common stock.
- This ownership represents 8.5% of the total class of Humana Inc. common stock.
- Dodge & Cox holds sole voting power over 9,631,475 shares and sole dispositive power over 10,198,040 shares.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Humana Inc.
- Dodge & Cox Stock Fund, an investment company registered under the Investment Company Act of 1940 and a client of Dodge & Cox, has an interest of 6,823,200 shares, representing 5.7% of the class of securities reported.
Sentiment
Score: 7
Explanation: The filing indicates a significant, passive institutional investment in Humana Inc., which can be viewed positively as a vote of confidence from a major asset manager. There are no negative implications for Humana Inc. directly from this filing.
Positives
- A major investment adviser, Dodge & Cox, holds a significant 8.5% stake in Humana Inc., indicating institutional confidence in the company.
Negatives
- None directly stated in this beneficial ownership filing.
Risks
- No specific risks related to Humana Inc.'s operations or financial health are disclosed in this beneficial ownership report.
Future Outlook
This Schedule 13G filing does not provide any forward-looking statements or guidance regarding Humana Inc.'s future outlook.
Management Comments
- The filing includes a certification from Katherine M. Primas, Chief Compliance Officer of Dodge & Cox, stating that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Humana Inc.
Industry Context
This filing reflects a significant passive investment by a prominent asset manager in the healthcare insurance sector, a highly regulated and essential industry. Such disclosures are common for large institutional investors holding substantial stakes in publicly traded companies.
Comparison to Industry Standards
- This beneficial ownership filing does not contain information for comparison to industry standards or specific comparable companies/projects.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's stake, potentially signaling confidence.
- Investment Community: Offers insight into major institutional holdings, which can influence market perception.
Next Steps
- No specific future actions or milestones for Humana Inc. are mentioned in this beneficial ownership filing.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (beneficial ownership calculation date). |
| 02/13/2025 | Date of filing of the Schedule 13G. |
Keywords
Humana Inc., Dodge & Cox, Schedule 13G, beneficial ownership, common stock, investment adviser, healthcare insurance, institutional investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.